238 related articles for article (PubMed ID: 25619468)
1. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma.
Young DL; Moore MM; Halstead LA
J Voice; 2015 Mar; 29(2):223-9. PubMed ID: 25619468
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis.
Hermann JS; Weckx LY; Monteiro Nürmberger J; Santos Junior GF; Campos Pignatari AC; Nagata Pignatari SS
Int J Pediatr Otorhinolaryngol; 2016 Apr; 83():94-8. PubMed ID: 26968061
[TBL] [Abstract][Full Text] [Related]
3. Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report.
Baumanis MM; Elmaraghy CA
Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():166-169. PubMed ID: 27863633
[TBL] [Abstract][Full Text] [Related]
4. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
Yiu Y; Fayson S; Smith H; Matrka L
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
[TBL] [Abstract][Full Text] [Related]
5. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
Ivancic R; Freeman T; de Silva B; Forrest A; Kim B; Matrka L
Laryngoscope; 2024 Jul; 134(7):3226-3229. PubMed ID: 38401115
[TBL] [Abstract][Full Text] [Related]
7. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Human Papillomavirus Vaccination as an Adjuvant Therapy in Recurrent Respiratory Papillomatosis.
Ponduri A; Azmy MC; Axler E; Lin J; Schwartz R; Chirilă M; Dikkers FG; Yang CJ; Mehta V; Gangar M
Laryngoscope; 2023 Sep; 133(9):2046-2054. PubMed ID: 36651338
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of recurrent respiratory papillomatosis : Retrospective analysis of juvenile and adult cases.
Papaioannou VA; Lux A; Voigt-Zimmermann S; Arens C
HNO; 2018 Jan; 66(Suppl 1):7-15. PubMed ID: 28840259
[TBL] [Abstract][Full Text] [Related]
10. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer.
Makiyama K; Hirai R; Matsuzaki H
J Voice; 2017 Jan; 31(1):104-106. PubMed ID: 27068425
[TBL] [Abstract][Full Text] [Related]
11. [Treatment outcomes of recurrent respiratory papillomatosis : Retrospective analysis of juvenile and adult cases. German version].
Papaioannou VA; Lux A; Voigt-Zimmermann S; Arens C
HNO; 2017 Nov; 65(11):923-932. PubMed ID: 28710539
[TBL] [Abstract][Full Text] [Related]
12. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
Hirai R; Makiyama K; Matsuzaki H; Oshima T
J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
[TBL] [Abstract][Full Text] [Related]
13. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.
Hočevar-Boltežar I; Matičič M; Sereg-Bahar M; Gale N; Poljak M; Kocjan B; Zargi M
Eur Arch Otorhinolaryngol; 2014 Dec; 271(12):3255-62. PubMed ID: 24964770
[TBL] [Abstract][Full Text] [Related]
15. Gardasil 9--a broader HPV vaccine.
Med Lett Drugs Ther; 2015 Mar; 57(1465):47-8. PubMed ID: 25853579
[No Abstract] [Full Text] [Related]
16. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
[TBL] [Abstract][Full Text] [Related]
17. A retrospective case-control analysis of the efficacy of Gardasil
Milner TD; Harrison A; Montgomery J; MacGregor FB; Buchanan MA; MacKenzie K
Clin Otolaryngol; 2018 Jun; 43(3):962-965. PubMed ID: 29380936
[No Abstract] [Full Text] [Related]
18. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
Katsuta T; Miyaji Y; Offit PA; Feemster KA
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.
Chirilă M; Bolboacă SD
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1135-42. PubMed ID: 24121781
[TBL] [Abstract][Full Text] [Related]
20. Voice and quality of life in patients with recurrent respiratory papillomatosis in a northern Sweden cohort.
Loizou C; Laurell G; Lindquist D; Olofsson K
Acta Otolaryngol; 2014 Apr; 134(4):401-6. PubMed ID: 24433057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
